Results
|
301.
|
Surgical techniques in the management of patients with superficial bladder cancer. [electronic resource] by
- Soloway, M S
- Kurth, K H
- Herr, H
- Huland, H
- Denis, L
- Suzuki, K
- Blandy, J
- Hisazumi, H
- Koontz, W
- Tsugawa, R
Producer: 19870313
In:
Progress in clinical and biological research vol. 221
Availability: No items available.
|
|
302.
|
Prognostic factors in superficial bladder cancer. [electronic resource] by
- Aso, Y
- Anderson, L
- Soloway, M
- Bouffioux, C
- Chisholm, G
- Debruyne, F
- Kawai, T
- Kurth, K H
- Maru, A
- Straffon, W G
Producer: 19870313
In:
Progress in clinical and biological research vol. 221
Availability: No items available.
|
|
303.
|
|
|
304.
|
|
|
305.
|
|
|
306.
|
|
|
307.
|
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group. [electronic resource] by
- Splinter, T A
- Scher, H I
- Denis, L
- Bukowski, R
- Simon, S
- Klimberg, I
- Soloway, M
- Vogelzang, N J
- van Tinteren, H
- Herr, H
Producer: 19920331
In:
The Journal of urology vol. 147
Availability: No items available.
|
|
308.
|
|
|
309.
|
|
|
310.
|
|
|
311.
|
|
|
312.
|
|
|
313.
|
|
|
314.
|
|
|
315.
|
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]. [electronic resource] by
- Hautmann, S H
- Schroeder, G L
- Civantos, F
- Duncan, R C
- Gnann, R
- Friedrich, M G
- Hellstern, A
- Huland, H
- Soloway, M S
- Lokeshwar, V B
Producer: 20010705
In:
Der Urologe. Ausg. A vol. 40
Availability: No items available.
|
|
316.
|
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa. [electronic resource] by
- Issell, B F
- Prout, G R
- Soloway, M S
- Cummings, K B
- Brannen, G
- Veenema, R
- Flanagan, M
- Block, N L
- Summers, J L
- Levin, E A
Producer: 19840319
In:
Cancer vol. 53
Availability: No items available.
|
|
317.
|
|
|
318.
|
Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life. [electronic resource] by
- Presant, C A
- Soloway, M S
- Klioze, S S
- Yakabow, A
- Presant, S N
- Mendez, R G
- Kennedy, P S
- Wyres, M R
- Naessig, V L
- Todd, B
Producer: 19870521
In:
Cancer vol. 59
Availability: No items available.
|
|
319.
|
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group. [electronic resource] by
- Schellhammer, P F
- Sharifi, R
- Block, N L
- Soloway, M S
- Venner, P M
- Patterson, A L
- Sarosdy, M F
- Vogelzang, N J
- Chen, Y
- Kolvenbag, G J
Producer: 19961217
In:
Cancer vol. 78
Availability: No items available.
|
|
320.
|
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group. [electronic resource] by
- Schellhammer, P F
- Sharifi, R
- Block, N L
- Soloway, M S
- Venner, P M
- Patterson, A L
- Sarosdy, M F
- Vogelzang, N J
- Schellenger, J J
- Kolvenbag, G J
Producer: 19971017
In:
Urology vol. 50
Availability: No items available.
|